Video assisted thoracoscopic surgery and lobectomy, sublobar resection, radiofrequency ablation, and stereotactic radiosurgery: Advances and controversies in the management of early stage non-small cell lung cancer

Current Opinion in Pulmonary Medicine

Volumn 13, Issue 4, 2007, Pages 267-270

  Pennathur, Arjun ^a   Abbas, Ghulam ^a   Christie, Neil ^a   Landreneau, Rodney ^a   Luketich, James D ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

High risk patients; Lung cancer; Radiofrequency ablation; Stereotactic radiosurgery; Video assisted thoracoscopy

Indexed keywords

BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; EARLY CANCER; ENDOSCOPIC SURGERY; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MINIMALLY INVASIVE SURGERY; RADIOFREQUENCY ABLATION; RADIOSURGERY; REVIEW; STEREOTAXIC SURGERY; SURGICAL TECHNIQUE; THORACOSCOPY; THORAX SURGERY;

CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; DECISION MAKING; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PNEUMONECTOMY; RADIOSURGERY; THORACIC SURGERY, VIDEO-ASSISTED; TREATMENT OUTCOME;

EID: 34249824597     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3281c61a85     Document Type: Review

References (23)

1. Sibley G, Jamieson T, Marks L, et al. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: The Duke experience. Int J Radiat Oncol Biol Phys 1998; 40:149-154.
2. McKenna RJ, Houck W, Fuller CB. Video-assisted thoracic surgery lobectomy: experience with 1100 cases. Ann Thorac Surg 2006; 81:421-426. This is a large series of 1100 patients who underwent VATS lobectomy.
3. Onaitis MW, Petersen RP, Balderson SS, et al. Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients. Ann Surg 2006; 244:420-425. This is another large single institution series in 500 consecutive patients who underwent thoracoscopic lobectomy.
4. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1N0 nonsmall cell lung cancer. Ann Thorac Surg 1995; 60:615-623.
5. Landreneau RJ, Sugarbaker DJ, Mack MJ, et al. Wedge resection versus lobectomy for stage I (T1 N0 M0) nonsmall-cell lung cancer. J Thorac Cardiovasc Surg 1997; 113:691-700.
6. El-Sherif A, Gooding WE, Santos R, et al. Outcomes of sublobar resection versus lobectomy for stage I nonsmall cell lung cancer: a 13-year analysis. Ann Thorac Surg 2006; 82:408-416. This is a large study evaluating the outcome of 784 patients with stage I non-small cell lung neoplasm.
7. Kraev A, Rassias D, Vetto J, et al. Wedge resection vs. lobectomy 10 year survival in stage I primary lung cancer. Chest 2007; 131:136-140. This interesting study of 289 patients with stage I NSCLC evaluated long term (10-year) survival.
8. El-Sherif A, Fernando HC, Santos R, et al. Margin and local recurrence after sublobar resection of NSCLC [abstract]. In: Presented at the Annual Society of Surgical Oncology meeting; Atlanta, Georgia; 2005.
9. Birdas TJ, Koehler RP, Colonias A, et al. Sublobar resection with brachytherapy versus lobectomy for stage IB nonsmall cell lung cancer. Ann Thorac Surg 2006; 81:434-438. This report compares sublobar resection with bracytherapy and lobectomy for stage IB NSCLC with equivalent results.
10. Santos R, Colonias A, Parda D, et al. Comparison between sublobar resection and 125 Iodine brachytherapy after sublobar resection in high risk patients with Stage I nonsmall-cell lung cancer. Surgery 2003; 134:691-697.
11. Fernando HC, Hoyos AD, Litle V, et al. Radiofrequency ablation: identification of the ideal patient. Clin Lung Cancer 2004; 6 (3):149-153.
12. Herrera LJ, Fernando HC, Perry Y, et al. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg 2003; 125:929-937.
13. Fernando HC, De Hoyos A, Landreneau RJ, et al. Radiofrequency ablation for the treatment of nonsmall cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 2005; 129:639-644.
14. Ambrogi MC, Lucchi M, Dini P, et al. Percutaneous radiofrequency ablation of lung tumours: results in the mid-term. Eur J Cardiothorac Surg 2006; 30:177-183.
15. Pennathur A, Luketich JD, Abbas G, et al. Radiofrequency ablation for the treatment of stage I nonsmall cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg (in press).
16. Dupuy DE, DiPetrillo T, Gandhi S, et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable Stage I nonsmall cell lung cancer. Chest 2006; 129:738-745. This is an interesting series of patients with stage I NSCLC who underwent RFA followed by conventional external beam radiation therapy. The estimated overall survival was 83% and 50% at 1 and 2 years respectively.
17. Uematsu M, Shioda A, Tahara K, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 1998; 82:1062-1070.
18. Wulf J, Haedinger U, Oppitz U, et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004; 60:186-196.
19. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high dose irradiation for Stage I nonsmall cell lung carcinoma. Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004; 101:1623-1631.
20. Whyte RI, Crownover R, Murphy MJ, et al. Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trial. Ann Thorac Surg 2003; 75:1097-1101.
21. Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radio-ablation. Results of a phase I study in medically inoperable stage I nonsmall cell lung cancer. Chest 2003; 124:1946-1955.
22. Pennathur A, Luketich JD, Burton S, et al. Stereotactic radiosurgery for the treatment of lung neoplasm: initial experience. Ann Thorac Surg 2007; 83:1820-1825. This article is a report of initial results in patients with both primary non-small cell lung neoplasm and metastatic tumors treated with SRS. The estimated overall 1-year survival in patients with stage I NSCLC was 91%.
23. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006; 24:4833-4839. This reports on a phase II study in 70 stage I non-small cell lung neoplasm patients who underwent stereotactic radiosurgery with a dose of 60-66 Gy in three fractions. The authors reported a significant increase in toxicity for central lesions with this dose.